Ontology highlight
ABSTRACT: Background
Recently, immune-checkpoint blockade has shown striking clinical results in different cancer patients. However, a significant inter-individual and inter-tumor variability exists among different cancers. The expression of the toxins granzyme A (GZMA) and perforin 1 (PRF1), secreted by effector cytotoxic T cells and natural killer (NK) cells, were recently used as a denominator of the intratumoral immune cytolytic activity (CYT). These levels are significantly elevated upon CD8+ T-cell activation as well as during a productive clinical response against immune-checkpoint blockade therapies. Still, it is not completely understood how different tumors induce and adapt to immune responses.Methods
Here, we calculated the CYT across different cancer types and focused on
SUBMITTER: Roufas C
PROVIDER: S-EPMC5826382 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature